The purpose of this study is to better understand the effectiveness and safety of microbiome therapies (MT) as a treatment for patients with Multidrug Resistan…

Intestinal Multi-drug Resistant Organism Colonization

~Estimated

~$10 – $6,250

Emory UniversityNCT05835206

Phase 2

Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy

REACT is a phase two, open-label, randomized, controlled trial of microbiota therapy (MT) to reduce colonization with multi-drug resistant organisms (MDRO). RE…

Multi-Drug Resistant Organism Colonization

~Estimated

~$10 – $6,250

Emory UniversityNCT06321536